In addition, TransCelerate executives and member organizations, such as Amgen, Eli Lilly, GSK, and more, will present 10 impactful sessions at the conference, addressing critical and relevant topics ...
This collaboration integrates Egnyte's Content Intelligence Engine and AI Copilot technology with Espero's AI-enabled Insights Driven Protocol Platform to deliver a comprehensive, intelligent solution ...
Vigil Neuroscience, Inc., a clinical-stage biotechnology company listed on the Nasdaq under the symbol VIGL, recently unveiled promising results from its Phase 1 clinical trial for the experimental ...
Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.
Launay et al compare the persistence of cross-neutralizing antibodies up to 3 months post-booster. The monovalent (MV) recombinant protein Beta-variant (MVB.1.351) vaccine induces higher and ...